Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Non-Current Deferred Tax Liability (2015 - 2021)

Mesoblast's (MEOBF) quarterly Non-Current Deferred Tax Liability came in at $7.9 million in Q4 2021, down 90.09% year-over-year from $80.1 million in Q4 2020, and up 5.08% quarter-over-quarter from $7.6 million in Q3 2021.

Analysis

Mesoblast (MEOBF) Non-Current Deferred Tax Liability (2015 - 2021) Analysis & Trends

Mesoblast has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $7.9 million for Q4 2021.

  • In Q4 2021, Non-Current Deferred Tax Liability fell 90.09% year-over-year to $7.9 million; the TTM figure through Dec 2021 stood at $7.9 million (down 90.09% YoY), while the FY2021 annual figure was $8.5 million, up 1062.33% from the prior year.
  • Non-Current Deferred Tax Liability came in at $7.9 million for Q4 2021 at Mesoblast, up from $7.6 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $80.2 million in Q1 2021 to a low of $730000.0 in Q2 2020.
  • Average Non-Current Deferred Tax Liability over 5 years is $28.1 million, with a median of $17.9 million recorded in 2018.
  • Year-over-year, Non-Current Deferred Tax Liability slumped 93.44% in 2020 and surged 1514.98% in 2021.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $23.9 million in 2017, then sank by 30.98% to $16.5 million in 2018, then slumped by 58.06% to $6.9 million in 2019, then jumped by 1057.43% to $80.1 million in 2020, then tumbled by 90.09% to $7.9 million in 2021.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $7.9 million in Q4 2021, $7.6 million in Q3 2021, and $8.5 million in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 7.94 Mn
Sep 30, 2021 7.56 Mn
Jun 30, 2021 8.49 Mn
Mar 31, 2021 80.20 Mn
Dec 31, 2020 80.12 Mn
Sep 30, 2020 79.91 Mn
Jun 30, 2020 730,000.00
Mar 31, 2020 4.97 Mn
Dec 31, 2019 6.92 Mn
Sep 30, 2019 9.20 Mn
Jun 30, 2019 11.12 Mn
Mar 31, 2019 14.30 Mn
Dec 31, 2018 16.50 Mn
Sep 30, 2018 19.37 Mn
Jun 30, 2018 20.08 Mn
Mar 31, 2018 21.10 Mn
Dec 31, 2017 23.91 Mn
Sep 30, 2017 46.40 Mn
Jun 30, 2017 49.29 Mn
Mar 31, 2017 53.37 Mn